Literature DB >> 3721286

Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

B J Rathbone, J I Wyatt, B W Worsley, S E Shires, L K Trejdosiewicz, R V Heatley, M S Losowsky.   

Abstract

Antibody titres to Campylobacter pyloridis in serum and gastric juice were estimated by an enzyme linked immunosorbent assay (ELISA) to whole organisms obtained from bacterial culture in 39 patients with non-ulcer dyspepsia. Whereas 20 of the 21 patients with chronic gastritis had gastric C pyloridis, 17 patients with no C pyloridis had normal histology in the gastric antrum and body. Significantly raised serum IgG and IgA antibody titres to C pyloridis were found in colonised patients with gastritis. Patients with raised IgG antibody to C pyloridis were also shown to have significantly raised titres to other Campylobacter species, suggesting antigenic cross reactivity. Gastric juice antibodies were also studied and IgA titres to C pyloridis were detected in a proportion of patients with gastritis, together with low levels of IgM, but no IgG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721286      PMCID: PMC1433340          DOI: 10.1136/gut.27.6.642

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Spiral bacteria of the gastric antrum.

Authors:  C A McNulty; D M Watson
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

2.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

3.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

4.  The detection and specificity of class specific antibodies to whole bacterial cells using a solid phase radioimmunoassay.

Authors:  C Czerkinsky; A S Rees; L A Bergmeier; S J Challacombe
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa.

Authors:  P Isaacson
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

6.  Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.

Authors:  K E Magnusson; I Stjernström
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

7.  Mucosal changes in gastric ulceration and their response to carbenoxolone sodium.

Authors:  H W Steer; D G Colin-Jones
Journal:  Gut       Date:  1975-08       Impact factor: 23.059

8.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens.

Authors:  R Whitehead; S C Truelove; M W Gear
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

10.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

View more
  88 in total

1.  Non-invasive testing for Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

Review 2.  An assessment of serological tests for detection of Helicobacter pylori.

Authors:  H von Wulffen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 3.  An approach to dyspepsia in the ambulatory care setting: evaluation based on risk stratification.

Authors:  S C Zell; M Budhraja
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

4.  Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

5.  Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.

Authors:  H Osawa; F Inoue; Y Yoshida
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

6.  Mucosal lymphocyte subsets and HLA-DR antigen expression in paediatric Helicobacter pylori-associated gastritis.

Authors:  A I Lopes; R M M Victorino; A M Palha; J Ruivo; A Fernandes
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

7.  Serum antibody against Helicobacter pylori assayed by a new capture ELISA.

Authors:  H Nakata; H Itoh; Y Yokoya; J Kawai; S Nishioka; K Miyamoto; N Kitamoto; H Miyamoto; T Tanaka
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

8.  Helicobacter pylori expresses a complex surface carbohydrate, Lewis X.

Authors:  R Sherburne; D E Taylor
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

10.  Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection.

Authors:  X J Fan; A Chua; M A O'Connell; D Kelleher; P W Keeling
Journal:  Ir J Med Sci       Date:  1993-10       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.